FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to oncology, and can be used for optimisation of treatment tactics in case of Hodgkin's lymphoma in children and teenagers. Method is realised in the following way. Such unfavourable prognostic factors as: age over 10 years, IV stage of disease, conglomerate dimensions more than 5 cm and/or value of mediastinal-thoracic index greater than 0.33, number of affected zones more than 4, symptoms of intoxication and biological activity of process. After that three risk groups are determined by the sum of detected unfavourable factors. In the first group, if 0-2 factors are detected, 2 cycles of polychemotherapy in accordance with regimen VBVP are carried out, in the second group, if 3-4 risk factors are detected - 4 cycles in alternating regimen VBVP-ABVD-VBVP-ABVD, in the third group, if 5-6 factors are detected - 6 cycles in alternating regimen VBVP-ABVD-VBVP-ABVD-VBVP-ABVD. Two weeks after carrying out polychemotherapy in all groups irradiation of all earlier affected zones is performed.
EFFECT: method allows to reduce risk of post-cytostatic and radiation complications development due to reduction of treatment loading in patients.
1 tbl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF INFERTILITY AFTER RISK-ADAPTED TREATMENT OF HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS | 2018 |
|
RU2688313C1 |
METHOD FOR OPTIMIZING TREATMENT TACTICS IN THE CASES OF INFANTINE LYMPHOGRANULOMATOSIS | 2001 |
|
RU2218861C2 |
METHOD FOR COMPLEX TREATMENT OF LYMPHOGRANULOMATOSIS | 2004 |
|
RU2299727C2 |
METHOD OF ESTIMATION TUMOUR MASS REGRESSION IN CASE OF HODGKIN LYMPHOMA | 2011 |
|
RU2462192C1 |
METHOD OF TREATING STAGE IIA HODGKIN'S LYMPHOMA | 2011 |
|
RU2457874C1 |
METHOD OF OPTIMISATION OF HODGKIN'S LYMPHOMA OF IIIA STAGE TREATMENT IN ADULTS | 2009 |
|
RU2400266C1 |
METHOD OF TREATING PATIENTS WITH REFRACTORY AND RECURRENT CLINICAL COURSE OF HODGKIN'S LYMPHOMA | 2012 |
|
RU2487727C1 |
METHOD OF PREDICTION OF SENSITIVITY TO ANTICANCER THERAPY OF HODGKIN'S LYMPHOMA | 2008 |
|
RU2393890C1 |
METHOD FOR COMPLEX TREATMENT OF LYMPHOGRANULEMATOSIS | 2003 |
|
RU2252764C2 |
METHOD FOR PREDICTING RISK OF PROGRESSION OF PRIMARY NON-HODGKIN'S LYMPHOMAS WITH BONE MARROW INVOLVEMENT | 2016 |
|
RU2647454C2 |
Authors
Dates
2009-11-27—Published
2007-12-18—Filed